SIREN : 434500187
POLYCLINIQUE DU PARC is a French company founded 25 years ago, specialized in the sector Activités des sociétés holding. Based in MAUBEUGE (59600), this company of category ETI shows in 2024 a revenue of 1.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 345 618 € | 1 258 318 € | 1 181 693 € | 1 124 464 € | 1 114 971 € | 694 405 € | 738 557 € | 1 112 468 € | 1 116 616 € |
| Net income | 776 928 € | 623 453 € | 558 559 € | 494 210 € | 518 607 € | 193 542 € | -132 147 € | 141 546 € | 401 961 € |
| EBITDA | 1 163 685 € | 1 068 106 € | 1 002 676 € | 912 167 € | 965 486 € | 581 445 € | 592 982 € | 925 134 € | 857 044 € |
| Net margin | 57.7% | 49.5% | 47.3% | 44.0% | 46.5% | 27.9% | -17.9% | 12.7% | 36.0% |
In 2024, POLYCLINIQUE DU PARC achieves revenue of 1.3 M€. Revenue is growing positively over 9 years (CAGR: +2.4%). Vs 2023: +7%. After deducting consumption (0 €), gross margin stands at 1.3 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 1.2 M€, representing 86.5% of revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 777 k€, i.e. 57.7% of revenue. This profit can be retained or distributed to shareholders.
1 345 618 €
1 345 618 €
1 163 685 €
919 117 €
776 928 €
86.5%
The debt ratio (= Financial debt / Equity x 100) stands at 4%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 95%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.4 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 75.5% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
4.382%
94.962%
75.472%
0.397
18.0%
In 2024, the debt ratio of POLYCLINIQUE DU PARC (4.38) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of POLYCLINIQUE DU PARC (95.0%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2024, the repayment capacity of POLYCLINIQUE DU PARC (0.40) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 8160.18. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 4.0x. Financial charges are adequately covered by operations.
8160.176
4.008
In 2024, the liquidity ratio of POLYCLINIQUE DU PARC (8160.18) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2024, the interest coverage of POLYCLINIQUE DU PARC (4.0x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 519 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 521 days. Favorable situation: supplier credit is longer than customer credit by 2 days. Overall, WCR represents 681 days of revenue, i.e. 2.5 M€ to permanently finance. Over 2016-2024, WCR increased by +49%, requiring additional financing.
2 544 967 €
519 j
521 j
0 j
681 j
Based on 54 transactions of similar company sales
in 2024,
the value of POLYCLINIQUE DU PARC is estimated at
3 278 238 €
(range 768 842€ - 6 291 878€).
With an EBITDA of 1 163 685€, the sector multiple of 4.8x is applied.
The price/revenue ratio is 0.59x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 54 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare POLYCLINIQUE DU PARC with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of POLYCLINIQUE DU PARC in 2024 is 1.3 M€.
Yes, POLYCLINIQUE DU PARC generated a net profit of 777 k€ in 2024.
The headquarters of POLYCLINIQUE DU PARC is located in MAUBEUGE (59600), in the department Nord.
The tax return of POLYCLINIQUE DU PARC is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
POLYCLINIQUE DU PARC operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.